Clinical Trials List
Protocol NumberOMS721-HUS-002
Completed
2018-02-01 - 2022-08-12
Phase III
Terminated1
ICD-10D59.3
Hemolytic-uremic syndrome
ICD-9283.11
Non-autoimmune hemolytic anemias, Hemolytic-uremic syndrome
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- YUNG-HO HSU Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- I-jen Chiu Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
80 participants
